MAR 2017
Eradicating cancer without damaging healthy tissue is the Holy Grail of cancer researchers.
Wills Eye Hospital in Philadelphia is testing a novel, light-activated drug designed to do just that in the eye, raising hopes for the first ocular melanoma treatment that would preserve patients’ vision. Sparing eyesight could encourage earlier detection and treatment, thus reducing the chance of metastases. You can read more about this new treatment here  https://www.aao.org/headline/fda-fast-tracks-ocular-melanoma-treatment
Note,
Ocumelirl does NOT promote any treatment, we only report what we find in our travels for your information. Please at all times take appropriate qualified professional medical advice. However medical science is moving so fast that your Dr may not yet be aware of what is happening in other areas so It might be of benefit to point out whats new when you consult with him/her.